Association of GLP-1 receptor agonist use with safety outcomes in individuals with opioid use disorder: a target trial emulation
Hussain T, Al Faysal J, Kotecha P, et al.
Diabetes Obes Metab. Pub. online 18 May 2026.
Leggi
Breaking news
Concordance between target trial emulation and randomised controlled trials: systematic review and meta-analysis
Wang C, Tang D, von Dadelszen P, et al.
BMJ. Pub. online 19 May 2026.
Leggi
MASLD prevalence, incidence and global aspects
Wild SH, Lazarus JV, Spearman CW, et al.
Diabetologia. Pub. online 21 May 2026.
Leggi
EMA. First oral GLP-1 treatment for weight management
22 maggio 2026
Leggi
Comparative associations of traditional and new obesity framework with cardio-kidney-metabolic syndrome and all-cause mortality: a prospective cohort study
Yang Y, Liu Y, Han S, et al.
Diabetes Obes Metab. Pub. online 21 May 2026.
Leggi
Screening children for early-stage type 1 diabetes
Winkler C, Friedl N, Abt R, et al.
JAMA. Pub. online 21 May 2026.
Leggi
Randomised controlled multicentre trial to investigate the effectiveness of a mobile artificial intelligence solution for diabetes adapted care: the MELISSA trial protocol
den Brok EJ, Svensson CH, Olsen MT, et al.
Diabetes Obes Metab. Pub. online 19 May 2026.
Leggi
Persistence of proinsulin-only secretion in people with long-duration diabetes and minimal residual insulin secretion
Metghalchi S, Bonnet-Serrano F, Alexandre L, et al.
Diabet Med. Pub. online 22 May 2026.
Leggi
Simplified switching to once-weekly insulin icodec without an initial one-time additional dose versus once-daily insulin glargine U100 in basal insulin-treated type 2 diabetes (ONWARDS 10): a randomised controlled trial
Rosenstock J, Mathieu C, Feinberg JBF, et al.
Diabetes Obes Metab. Pub. online 21 May 2026.
Leggi
The effects of combined antihypertensive and antidiabetic therapies on cardiovascular outcomes: a systematic review and meta-analysis
Hsieh WC, Henry BM, Édes I
Diabetes Obes Metab. Pub. online 20 May 2026.
Leggi